SAREPTA THERAPEUTICS INC

CUSIP: 803607AD2 Class: Convertible Debt

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 16,897,000 Value ($000) $15,239 Avg Close Range
Q3 2025
Shares 30,897,000 Value ($000) $27,126 Avg Close Range
Q2 2025
Shares 5,500,000 Value ($000) $4,063 Avg Close Range
Q1 2024
Shares 30,977,000 Value ($000) $36,246 Avg Close Range
Q4 2023
Shares 36,477,000 Value ($000) $36,991 Avg Close Range
Q3 2023
Shares 28,477,000 Value ($000) $31,891 Avg Close Range